Novartis and Alcon deliver solid results
Wednesday, November 12 2014 | 00 h 00 min | Financial News
Novartis and its Alcon division delivered a good performance in the third quarter of 2014.
Novartis recorded net sales of CA$16.5 billion, a 4% increase compared with the same period last year.
Alcon’s third-quarter sales were CA$3 billion, a 5% increase over the same period in 2013. Alcon reported an increase of 3% in its pharmaceutical ophthalmic products, and a 3% increase in its vision care products. In the vision care segment, the strong sales growth of Dailies Total and AirOptix Colors contact lenses offset a decline in contact lens care solutions.